UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Momelotinib: an emerging treatment for myelofibrosis patients with anemia

Journal of hematology and oncology, 2022-01, Vol.15 (1), p.7-7, Article 7

2022

Volltextzugriff (PDF)

Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments

Cancers, 2023-06, Vol.15 (13), p.3331

2023

Volltextzugriff (PDF)

Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes

Nature communications, 2024-03, Vol.15 (1), p.2428-2428, Article 2428

2024

Volltextzugriff (PDF)

ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis

Cancers, 2023-12, Vol.16 (1), p.154

2023

Volltextzugriff (PDF)

Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update

Cancers, 2022-07, Vol.14 (14), p.3474

2022

Volltextzugriff (PDF)

Anion−π Interactions in Supramolecular Architectures

Accounts of chemical research, 2013-04, Vol.46 (4), p.894-906

2013

Volltextzugriff (PDF)

Anion Template Effect on the Self-Assembly and Interconversion of Metallacyclophanes

Journal of the American Chemical Society, 2005-09, Vol.127 (37), p.12909-12923

2005

Volltextzugriff (PDF)

Anion-pi interactions

Chemical Society reviews, 2008-01, Vol.37 (1), p.68-83

2008

Volltextzugriff (PDF)

SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic Mastocytosis

Clinical lymphoma, myeloma and leukemia, 2024-06

2024

Volltextzugriff (PDF)

SOHO State of the Art Update and Next Questions: Novel Therapies for Polycythemia Vera

Clinical lymphoma, myeloma and leukemia, 2024-03, Vol.24 (3), p.141-148

2024

Volltextzugriff (PDF)

Supramolecular Architectures with π‑Acidic 3,6-Bis(2-pyridyl)-1,2,4,5-tetrazine Cavities: Role of Anion−π Interactions in the Remarkable Stability of Fe(II) Metallacycles in Solution

Journal of the American Chemical Society, 2013-02, Vol.135 (8), p.3039-3055

2013

Volltextzugriff (PDF)

SOHO State of the Art Updates and Next Questions: Novel Therapeutic Strategies in Development for Myelofibrosis

Clinical lymphoma, myeloma and leukemia, 2023-04, Vol.23 (4), p.219-231

2023

Volltextzugriff (PDF)

Mutational landscape of blast phase myeloproliferative neoplasms (MPN-BP) and antecedent MPN

International review of cell and molecular biology, 2022, Vol.366, p.83-124

2022

Volltextzugriff (PDF)

π-Accepting Arene HAT(CN)₆ as a Halide Receptor through Charge Transfer: Multisite Anion Interactions and Self-Assembly in Solution and the Solid State

Angewandte Chemie (International ed.), 2010-09, Vol.49 (40), p.7202-7207

2010

Volltextzugriff (PDF)

EXABS-164-MPN Novel Therapeutics in Development for Myelofibrosis

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22 Suppl 2, p.S72-S74

2022

Volltextzugriff (PDF)

Accelerated Phase of Myeloproliferative Neoplasms

Acta haematologica, 2021-01, Vol.144 (5), p.484-499

2021

Volltextzugriff (PDF)

Improved survival of patients with myelofibrosis in the last decade: Single‐center experience

Cancer, 2022-04, Vol.128 (8), p.1658-1665

2022

Volltextzugriff (PDF)

Interactions of Metal−Metal-Bonded Antitumor Active Complexes with DNA Fragments and DNA

Accounts of chemical research, 2005-02, Vol.38 (2), p.146-156

2005

Volltextzugriff (PDF)

2D NMR Study of the DNA Duplex d(CTCTCAACTTCC)·d(GGAAGTTGAGAG) Cross-Linked by the Antitumor-Active Dirhodium(II,II) Unit at the Cytosine−Adenine Step

Biochemistry (Easton), 2008-02, Vol.47 (8), p.2265-2276

2008

Volltextzugriff (PDF)

Ponatinib‐review of historical development, current status, and future research

American journal of hematology, 2024-08, Vol.99 (8), p.1576-1585

2024

Volltextzugriff (PDF)

Head‐to‐Head Right‐Handed Cross‐Links of the Antitumor‐Active Bis(μ‐N,N′‐di‐p‐tolylformamidinato)dirhodium(II,II) Unit with the Dinucleotides d(GpA) and d(ApG)

Chemistry : a European journal, 2008-11, Vol.14 (32), p.9902-9913

2008

Volltextzugriff (PDF)

Biological drivers of clinical phenotype in myelofibrosis

Leukemia, 2023-02, Vol.37 (2), p.255-264

2023

Volltextzugriff (PDF)

New Therapies in Development for Myelofibrosis

Clinical lymphoma, myeloma and leukemia, 2020-09, Vol.20, p.S69-S71

2020

Volltextzugriff (PDF)

The role of therapy in the outcome of patients with myelofibrosis

Cancer, 2023-09, Vol.129 (18), p.2828-2835

2023

Volltextzugriff (PDF)

Covalent Binding and Interstrand Cross-Linking of Duplex DNA by Dirhodium(II,II) Carboxylate Compounds

Biochemistry (Easton), 2005-01, Vol.44 (3), p.996-1003

2005

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(59)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Chemistry
(24)
Physical Sciences
(23)
Life Sciences & Biomedicine
(20)
Organometallic Compounds - Chemistry
(14)
Chemistry, Multidisciplinary
(13)
Models, Molecular
(11)
Chemistry, Inorganic & Nuclear
(10)
Humans
(10)
Oncology
(10)
Rhodium - Chemistry
(10)
Antineoplastic Agents - Chemistry
(9)
Hematology
(9)
Myelofibrosis
(9)
Ligands
(8)
Magnetic Resonance Spectroscopy
(8)
Review
(8)
Dna - Chemistry
(7)
Dna Adducts - Chemistry
(6)
Guanine - Chemistry
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Momelotinib: an emerging treatment for myelofibrosis patients with anemia

Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments

Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes

ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis

Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update

Anion−π Interactions in Supramolecular Architectures

Anion Template Effect on the Self-Assembly and Interconversion of Metallacyclophanes

Anion-pi interactions

SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic Mastocytosis

SOHO State of the Art Update and Next Questions: Novel Therapies for Polycythemia Vera

Supramolecular Architectures with π‑Acidic 3,6-Bis(2-pyridyl)-1,2,4,5-tetrazine Cavities: Role of Anion−π Interactions in the Remarkable Stability of Fe(II) Metallacycles in Solution

SOHO State of the Art Updates and Next Questions: Novel Therapeutic Strategies in Development for Myelofibrosis

Mutational landscape of blast phase myeloproliferative neoplasms (MPN-BP) and antecedent MPN

π-Accepting Arene HAT(CN)₆ as a Halide Receptor through Charge Transfer: Multisite Anion Interactions and Self-Assembly in Solution and the Solid State

EXABS-164-MPN Novel Therapeutics in Development for Myelofibrosis

Accelerated Phase of Myeloproliferative Neoplasms

Improved survival of patients with myelofibrosis in the last decade: Single‐center experience

Interactions of Metal−Metal-Bonded Antitumor Active Complexes with DNA Fragments and DNA

2D NMR Study of the DNA Duplex d(CTCTCAACTTCC)·d(GGAAGTTGAGAG) Cross-Linked by the Antitumor-Active Dirhodium(II,II) Unit at the Cytosine−Adenine Step

Ponatinib‐review of historical development, current status, and future research

Head‐to‐Head Right‐Handed Cross‐Links of the Antitumor‐Active Bis(μ‐N,N′‐di‐p‐tolylformamidinato)dirhodium(II,II) Unit with the Dinucleotides d(GpA) and d(ApG)

Biological drivers of clinical phenotype in myelofibrosis

New Therapies in Development for Myelofibrosis

The role of therapy in the outcome of patients with myelofibrosis

Covalent Binding and Interstrand Cross-Linking of Duplex DNA by Dirhodium(II,II) Carboxylate Compounds

Suchergebnisse filtern